Lipids Unresolved- The Lipids Unresolved webcast reviews the latest research, knowledge, and skills needed to identify patients who remain at risk for cardiovascular (CV) events, and evaluate emerging strategies that decrease residual CV risk. Expert faculty presenters include their perspectives and interpretations of current clinical trial data regarding the future management of patients with cardiovascular disease. Discuss the effect of HDL-C level on risk for CHD. Explain controversies regarding statins, inflammation, and the JUPITER study. Discuss the effect of cholesteryl ester transfer protein inhibitors and modulators on HDL-C remodeling. Assess the potential benefits of niacin beyond its lipid effects.
Indicate the frequency and secondary causes of statin intolerance and treatment options for statin-intolerant patients. Review the scientific research publications relating to adherence to lipid-lowering therapies and the potential impact on current treatment decisions.
2.5 FREE AMA Pra Cat 1 CMEs for Physicians
Expires 1/20/13